(366 days)
Not Found
No
The device description focuses on the material composition, manufacturing process, and physical characteristics of a contact lens. There is no mention of any software, algorithms, or data processing that would suggest the use of AI or ML. The 510(k) summary explicitly states "Mentions AI, DNN, or ML: Not Found".
No
The device is a contact lens intended for the correction of visual acuity and enhancing eye color, not for treating a disease or therapeutic purpose.
No
This device is a contact lens designed to correct visual acuity in individuals with myopia or hyperopia and mild astigmatism. Its purpose is to correct vision, not to diagnose a medical condition.
No
The device description clearly states it is a physical contact lens made of hydrogel material, containing pigments and supplied in glass vials. This is a hardware device, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the correction of visual acuity in the eye. This is a direct interaction with the body for a therapeutic purpose (correcting vision).
- Device Description: The device is a contact lens, which is a medical device placed on the surface of the eye.
- Lack of IVD Characteristics: The description does not mention any analysis of samples taken from the body (like blood, urine, tissue, etc.) to provide information about a physiological state, disease, or condition. IVDs are used in vitro (outside the body) to perform tests.
Therefore, the Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens is a medical device, specifically a contact lens, but not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens is indicated for daily wear for the correction of visual acuity in not-aphakic persons with non-diseased eyes that are myopic or hyperopic and may exhibit refractive astigmatism up to 2.00 diopters that does not interfere with visual acuity."
Eye care practitioners may prescribe the lenses for either single-use daily disposable wear or frequent/planned replacement wear with cleaning, rinsing, disinfection and scheduled replacement as prescribed by the eye care professional. When prescribed for frequent/planned replacement wear The contact lens may be disinfected using chemical (not heat) disinfection system.
Product codes
LPL
Device Description
Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear is available as aspherical lenses manufactured by spin-casting method. The model illuminated with high water content (58 %).
The hydrogel lens' material is a random copolymer composed of 2-hydroxyethyl methacrylate (HEMA) and methacrylic acid (MAA), which was cross-linked with 1,1-trimethylolpropane trimethacrylate (TMPTMA) and Ethylene Glycol Dimethacrylate (EGDMA) via UV photo- polymerization. The Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear contains pigments around the non-optic area that will mask or enhance the color of the natural iris without blocking the light transmittance. The lens is colored with one or more of the FDA-approval color additives: iron oxides, titanium dioxide, phthalocyaninato copper, phtalocyanine green, vat orange 1. The Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear is available in the following opaque colors: Blue, green, violet, gray, hazel, white, yellow, gold, orange red and black. Lenses are supplied sterile in sealed glass vials containing sterile isotonic phosphate buffered saline solution.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
eyes
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Eye care practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
This special 510(k) application describes a labeling modification to the predicate device -- Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060 INNOVA VISION INC.. There is no change in lens material, the manufacturing process, nor the parameter and properties. The difference between predicate and subject device is packaging vehicles. Namely, the predicate device is pp blister packaging and that of subject device is glass vials. Therefore, the clinical data previously submitted in K073060 supports the clinical safety of the subject device.
All testing was conducted in accordance with the May 1994 FDA guideline titled Premarket Notification 510(K) Guidance Document for Class IV Contact lenses, and in conformance to applicable device regulations.
This special 510(k) application describes a labeling modification to the predicate device -- Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060. There is no change in lens material, the manufacturing process, nor the parameter and properties. Therefore, the non-clinical data previously submitted in K073060 supports the clinical safety of the non-clinical performance tests had been performed to demonstrate the safety and effectiveness of the Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens, and establish substantial equivalence to predicate lenses-Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060. The evidence of substantial equivalent to the predicate lens described as follow:
a) Technological characteristics studies
There characterizations of Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens are equivalent and comparable to those of predicate lenses.
b) Biocompatibility
In accordance with the May 1994 Guidance Document for daily wear contact lenses, toxicity studies have been conducted on the predicate model: Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens. The Irritation test in the rabbit eye and Systemic toxicity studies indicate the extracts would be considered as non-toxic and nor irritated. TThe Cytotoxicity testing demonstrates the lens is not cytotoxic under the conditions of the study. There is no change in lens material, the manufacturing process, nor the parameter and properties between subject device and that of predicate lens. Therefore, there are no biocompatibility risks for subject device-l: Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens.
c) Microbiology
Steam sterilization process has been validated to deliver a minimum SAL of 100, thereby complying with the requirement of FDA Group IV. There is shelf-life stability data supporting that the lens remains sterile through the expiration date claimed for the product.
d) Leachability
Studies were conducted to determine the leachable materials from the finished lens. The results show that, at the levels of the detection reported, there are no leachable monomers and addictive residues.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
Image /page/0/Picture/0 description: The image shows the logo for I-Lux Innova. The logo is in black and white. The text is in a serif font. The "I" in "I-Lux" is a thick, vertical line.
KII2373
INNOVA VISION, INC. No.231-1, Wen-Te Road, Chiung-Lin Village, Hsin-Chu County,307, Taiwan, R.O.C. TEL:886-3-5927299 FAX:886-3-5926213
510 (K) Summary
AUG 1 7 2012
SUMMARY OF SAFETY AND EFFECTIVENESS FOR Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear
Submitter Information:
| Company: | INNOVA VISION INC. |
|---|---|
| No. 231-1, Wen-Te Road, Chiung-lin Village, Hsin-Chu County, Taiwan. | |
| Contact Person: | Mr. Michael w. Hsu, |
| Executive Vice President | |
| Phone: | 886-3-592-7299 |
| FAX: | 886-3-592-6213 |
| E-Mail: | mikehsu@innovavision.com.tw |
| Date Prepared | July 4, 2011 |
ldentification of Device:
| Classification Name: | Soft hydrophilic contact lens, per 21 CFR. 886.5925 |
|---|---|
| Trade Name: | Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear |
| Common or usual Name: | Soft (hydrophilic) Contact lens (daily wear) |
| FDA Classification: | Class II |
Predicate Device:
Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060 from INNOVA VISION INC.
Indications for Use
Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens is indicated for daily wear for the correction of visual acuity in not-aphakic persons with non-diseased eyes that are myopic or hyperopic and may exhibit refractive astigmatism up to 2.00 diopters that does not interfere with visual acuity."
Eye care practitioners may prescribe the lenses for either single-use daily disposable wear or frequent/planned replacement wear with cleaning, rinsing, disinfection and scheduled replacement as prescribed by the eye care professional. When prescribed for frequent/planned replacement wear The contact lens may be disinfected using chemical (not heat) disinfection system.
Description of Device
Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear is available as aspherical lenses manufactured by spin-casting method. The model illuminated with high water content (58 %).
1
Image /page/1/Picture/0 description: The image shows the logo for I-Lux Innova. The word "Lux" is circled. To the right of "Lux" is the word "Innova".
No.231-1. Wen-Te Road. Chiung-Lin Village. Hsin-Chu County,307, Taiwan, R.O.C. TEL:886-3-5927299 FAX:886-3-5926213
The hydrogel lens' material is a random copolymer composed of 2-hydroxyethyl methacrylate (HEMA) and methacrylic acid (MAA), which was cross-linked with 1,1-trimethylolpropane trimethacrylate (TMPTMA) and Ethylene Glycol Dimethacrylate (EGDMA) via UV photo- polymerization. The Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear contains pigments around the non-optic area that will mask or enhance the color of the natural iris without blocking the light transmittance. The lens is colored with one or more of the FDA-approval color additives: iron oxides, titanium dioxide, phthalocyaninato copper, phtalocyanine green, vat orange 1. The Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear is available in the following opaque colors: Blue, green, violet, gray, hazel, white, yellow, gold, orange red and black. Lenses are supplied sterile in sealed glass vials containing sterile isotonic phosphate buffered saline solution.
Summary of Clinical Study
This special 510(k) application describes a labeling modification to the predicate device -- Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060 INNOVA VISION INC.. There is no change in lens material, the manufacturing process, nor the parameter and properties. The difference between predicate and subject device is packaging vehicles. Namely, the predicate device is pp blister packaging and that of subject device is glass vials. Therefore, the clinical data previously submitted in K073060 supports the clinical safety of the subject device.
Nonclinical Studies
All testing was conducted in accordance with the May 1994 FDA guideline titled Premarket Notification 510(K) Guidance Document for Class IV Contact lenses, and in conformance to applicable device regulations.
This special 510(k) application describes a labeling modification to the predicate device -- Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060. There is no change in lens material, the manufacturing process, nor the parameter and properties. Therefore, the non-clinical data previously submitted in K073060 supports the clinical safety of the non-clinical performance tests had been performed to demonstrate the safety and effectiveness of the Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens, and establish substantial equivalence to predicate lenses-Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060. The evidence of substantial equivalent to the predicate lens described as follow:
2
Image /page/2/Picture/0 description: The image shows the logo for I-Lux Innova. The logo is in black and white and features the text "I-Lux Innova" in a stylized font. The "I" in "I-Lux" is a large, bold vertical line, and the "Lux" is in a smaller font and enclosed in a partial oval. The word "Innova" is to the right of "I-Lux" and is in a similar font. There is a registered trademark symbol in the upper right corner of the logo.
INNOVA No 231-1 Wen-Te R -Lin Village. Hsin-Chu County,307, Taiwan, R.O.C TEL:886-3-5927299 FAX:886-3-5926213
a) Technological characteristics studies
There characterizations of Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens are equivalent and comparable to those of predicate lenses.
| Characteristic | Predicate Device | Subject Device |
|---|---|---|
| Calaview | Calaview Color | |
| %Water content | 57 to 59 | 57 to 59 |
| Refractive index | 1.407 | 1.407 |
| Specific Gravity | 1.05 | 1.05 |
| Oxygen permeability (edged corrected) @ 35°C | $24\times10^{-11}$ [(cm2/sec)(ml O2/ml-mmHg)] | $24\times10^{-11}$ [(cm2/sec)(ml O2/ml-mmHg)] |
| %Light Transmission | >93 | >93 |
| Base Curve Radius, mm | 8.00~9.00 | 8.00~9.00 |
| Diameter, mm | 13.8~14.2 | 13.8~14.2 |
| Center Thickness @-3.0D, mm | 0.08~0.12 | 0.08~0.12 |
| Power, Diopters | +6.0D~-12.0D | +6.0D~-12.0D |
b) Biocompatibility
In accordance with the May 1994 Guidance Document for daily wear contact lenses, toxicity studies have been conducted on the predicate model: Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens. The Irritation test in the rabbit eye and Systemic toxicity studies indicate the extracts would be considered as non-toxic and nor irritated. TThe Cytotoxicity testing demonstrates the lens is not cytotoxic under the conditions of the study. There is no change in lens material, the manufacturing process, nor the parameter and properties between subject device and that of predicate lens. Therefore, there are no biocompatibility risks for subject device-l: Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens.
c) Microbiology
Steam sterilization process has been validated to deliver a minimum SAL of 100, thereby complying with the requirement of FDA Group IV. There is shelf-life stability data supporting that the lens remains sterile through the expiration date claimed for the product.
d) Leachability
Studies were conducted to determine the leachable materials from the finished lens. The results show that, at the levels of the detection reported, there are no leachable monomers and addictive residues.
3
Image /page/3/Picture/0 description: The image shows the logo for "I-Lux Innova". The logo is in black and white, with the "I-Lux" portion of the logo enclosed in a partial circle. To the right of "I-Lux" is the word "Innova", and a registered trademark symbol is in the upper right corner of the logo.
K//2373
VISION INC
INNOVA V No.231-1, Wen-Te Road, Chiung-Lin Village, Hsin-Chu County,307, Taiwan, R.O.C. TEL:886-3-5927299 FAX:886-3-5926213
Substantial equivalence Statement
Testing performed on the Calaview Color Soft (hydrophilic) Contact Lens for Daily Wear indicated that it can support the safety and effectiveness as well as the predicate devices- Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear (K073060), when used in accordance with the instructions for Moreover, the Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear has use. identical lens material, manufacturing process, parameters and properties as the predicate device --Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K073060 INNOVA VISION INC..
In conclusion, it is Innova's conviction that data submitted in this 510(k) to validate the claim of substantial equivalency, substantiates our ability to manufacture a soft contact lens, the Calaview Color Soft (hydrophilic) Contact Lens, with the same established safety profile and effectiveness as the predicate device -- Calaview (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear (K073060).
4
Image /page/4/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS) of the United States. The seal features a stylized eagle with its wings spread, symbolizing protection and care. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle, indicating the department's name and national affiliation. The seal is presented in black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
Innova Vision, Inc. c/o Ms. Jennifer Reich Harvest Consulting Corp. 2904 N. Boldt Drive Flagstaff, AZ 86001
AUG 1 7 2012
Re: K112373
Trade Name: Calaview (etafilcon A) Soft (Hydrophilic) Contact Lens for Daily Wear Regulation Number: 21 CFR 886.5925 Regulatory Class: II Product Code: LPL Dated: July 9, 2012 Received: July 19, 2012
Dear Ms. Reich:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set
5
Page 2 - Ms. Jennifer Reich
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Kesia Alexander
Malvina B. Eydelman, M.D. Director
Division of Ophthalmic. Neurological, and Ear. Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
Image /page/6/Picture/0 description: The image shows the logo for "I-Lux Innova". The logo is black and white and features a stylized "I" with a curved line extending from the top of the "I" and wrapping around the word "Lux". The word "Innova" is written in a cursive font to the right of "Lux", and a registered trademark symbol is located in the upper right corner of the logo.
INNOVA VISION, INC. No.231-1, Wen-Te Road, Chiung-Lin Village, Hsin-Chu County,307, Taiwan, R.O.C. TEL:886-3-5927299 FAX:886-3-5926213
INDICATIONS FOR USE STATEMENT
510(k) Number: K112373
Device Name: Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear
Indications for Use:
Calaview Color (Etafilcon A) Soft (hydrophilic) Contact Lens is indicated for daily wear for the correction of visual acuity in not-aphakic persons with non-diseased eyes that are myopic or hyperopic and may exhibit refractive astigmatism up to 2.00 diopters that does not interfere with visual acuity.
Eye care practitioners may prescribe the lenses for either single-use daily disposable wear or frequent/planned replacement wear with cleaning, rinsing, disinfection and scheduled replacement as prescribed by the eye care professional. When prescribed for frequent/ planned replacement wear, the contact lens may be disinfected using chemical (not heat) disinfection system.
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices
(Division Sign-Off) Division of Ophthalmic Ear, Nose and Throat Devices
510(k) Number K112373
Prescription Use:
or
Over the Counter Use: